BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ye L, Guan S, Zhang C, Lee KH, Sun S, Wei J, Liu B. Circulating autoantibody to FOXP3 may be a potential biomarker for esophageal squamous cell carcinoma. Tumour Biol. 2013;34:1873-1877. [PMID: 23483489 DOI: 10.1007/s13277-013-0729-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Wang H, Yang X, Sun G, Yang Q, Cui C, Wang X, Ye H, Dai L, Shi J, Zhang J, Wang P. Identification and Evaluation of Autoantibody to a Novel Tumor-Associated Antigen GNA11 as a Biomarker in Esophageal Squamous Cell Carcinoma. Front Oncol 2021;11:661043. [PMID: 34568004 DOI: 10.3389/fonc.2021.661043] [Reference Citation Analysis]
2 Perisetti A, Bellamkonda M, Konda M, Edwards S, Ali Khan S, Bansal P, Hu ZD, Goyal H. Tumor-associated antigens and their antibodies in the screening, diagnosis, and monitoring of esophageal cancers. Eur J Gastroenterol Hepatol 2020;32:779-88. [PMID: 32243347 DOI: 10.1097/MEG.0000000000001718] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Wang J, Xu Y, Wang Y, Zhang X, Zhang G. Further Study of Circulating Antibodies to P16, CD25 and FOXP3 in Hepatocellular Carcinoma. Onco Targets Ther 2019;12:10487-93. [PMID: 31819529 DOI: 10.2147/OTT.S226404] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Khan T, Relitti N, Brindisi M, Magnano S, Zisterer D, Gemma S, Butini S, Campiani G. Autophagy modulators for the treatment of oral and esophageal squamous cell carcinomas. Med Res Rev 2020;40:1002-60. [PMID: 31742748 DOI: 10.1002/med.21646] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
5 Xu YW, Peng YH, Xu LY, Xie JJ, Li EM. Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma. World J Gastroenterol 2019; 25(34): 5049-5068 [PMID: 31558856 DOI: 10.3748/wjg.v25.i34.5049] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
6 Zhao H, Zhang X, Han Z, Xie W, Yang W, Wei J. Alteration of circulating natural autoantibodies to CD25-derived peptide antigens and FOXP3 in non-small cell lung cancer. Sci Rep 2018;8:9847. [PMID: 29959381 DOI: 10.1038/s41598-018-28277-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
7 Zhang JB, Cao M, Chen J, Ye SR, Xie K, He X, Ma XL, Zhang J, Yie SM. Serum anti-TOPO48 autoantibody as a biomarker for early diagnosis and prognosis in patients with esophageal squamous cell carcinoma. Clin Res Hepatol Gastroenterol. 2018;42:276-284. [PMID: 29170084 DOI: 10.1016/j.clinre.2017.09.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
8 Liu Y, Liao Y, Xiang L, Jiang K, Li S, Huangfu M, Sun S. A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer. Int J Clin Oncol 2017;22:291-6. [DOI: 10.1007/s10147-016-1047-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
9 Huangfu M, Xu S, Li S, Sun B, Lee K, Liu L, Sun S. A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with cervical cancer. Tumor Biol 2016;37:8709-14. [DOI: 10.1007/s13277-015-4472-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
10 Gao QY, Fang JY. Early esophageal cancer screening in China. Best Pract Res Clin Gastroenterol 2015;29:885-93. [PMID: 26651250 DOI: 10.1016/j.bpg.2015.09.018] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
11 Xu S, Huangfu M, Jia X, Song X, Sun B, Lee K, Liu L, Sun S. FOXP3 autoantibody as a potential early prognostic serum biomarker in patients with cervical cancer. Int J Clin Oncol 2015;20:982-8. [DOI: 10.1007/s10147-015-0797-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
12 Chen C, Huang Y, Zhang C, Liu T, Zheng HE, Wan S, Sun S, Meng Q, Chen Y, Wei J. Circulating antibodies to p16 protein-derived peptides in breast cancer. Mol Clin Oncol 2015;3:591-4. [PMID: 26137272 DOI: 10.3892/mco.2015.485] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
13 Zhang H, Xia J, Wang K, Zhang J. Serum autoantibodies in the early detection of esophageal cancer: a systematic review. Tumour Biol. 2015;36:95-109. [PMID: 25433500 DOI: 10.1007/s13277-014-2878-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
14 Gaur P, Kim MP, Dunkin BJ. Esophageal cancer: Recent advances in screening, targeted therapy, and management. J Carcinog 2014;13:11. [PMID: 25395880 DOI: 10.4103/1477-3163.143720] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
15 Lacombe J, Mangé A, Solassol J. Use of autoantibodies to detect the onset of breast cancer. J Immunol Res. 2014;2014:574981. [PMID: 25143958 DOI: 10.1155/2014/574981] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
16 Jin Y, Guan S, Liu L, Sun S, Lee KH, Wei J. Anti-p16 autoantibodies may be a useful biomarker for early diagnosis of esophageal cancer. Asia Pac J Clin Oncol. 2015;11:e37-e41. [PMID: 24811068 DOI: 10.1111/ajco.12198] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
17 Wang W, Guan S, Sun S, Jin Y, Lee KH, Chen Y, Wei J. Detection of circulating antibodies to linear peptide antigens derived from ANXA1 and DDX53 in lung cancer. Tumour Biol 2014;35:4901-5. [PMID: 24453033 DOI: 10.1007/s13277-014-1643-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
18 Zhang Q, Chen X, Tang Y, Ge L, Guo B, Yao C. Amperometric carbohydrate antigen 19-9 immunosensor based on three dimensional ordered macroporous magnetic Au film coupling direct electrochemistry of horseradish peroxidase. Anal Chim Acta 2014;815:42-50. [PMID: 24560371 DOI: 10.1016/j.aca.2014.01.033] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
19 Liu T, Song YN, Shi QY, Liu Y, Bai XN, Pang D. Study of circulating antibodies against CD25 and FOXP3 in breast cancer. Tumour Biol 2014;35:3779-83. [PMID: 24347486 DOI: 10.1007/s13277-013-1500-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
20 Zhang C, Ye L, Guan S, Jin S, Wang W, Sun S, Lee K, Wei J, Liu B. Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer. Tumor Biol 2014;35:2047-51. [DOI: 10.1007/s13277-013-1271-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]